NCT04172272

Brief Summary

This study evaluates the influence of the transversus abdominis plane block on the intensity of postoperative pain and the concentration of proinflammatory and pain factors after hysterectomy by laparotomy. The patients will be randomized in three groups.In the first group, patients will receive intravenous, systemic, multimodal analgesia.In the second group there will be patients in who will be given the TAP block. The TAP block will be given postoperatively before waking. It will be given bilaterally in the before mentioned anatomic region (the so-called lateral TAP block). In the third group there will be patients who will be treated with TAP block in addition to systemic, mutimodal analgesia. The research will be based on completing a questionnaire (VAS scale and QoR questionnaire) and taking peripheral blood out. We expect that the concentration of proinflammatory and pain factors in patients treated with a TAP block will be lower and the quality of recovery will be better than that of patients receiving standard analgesic therapy (systemic multimodal analgesia).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 24, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 21, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 24, 2020

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

November 21, 2019

Status Verified

November 1, 2019

Enrollment Period

1 year

First QC Date

November 8, 2019

Last Update Submit

November 20, 2019

Conditions

Keywords

Transversus abdominis plane blockLaparotomyHysterectomyPostoperative painCytokinesVisual analogue scaleQuality of recovery

Outcome Measures

Primary Outcomes (3)

  • The impact of three forms of postoperative analgesia (TAP block, systemic multimodal analgesia, combined TAP block and systemic multimodal analgesia)on postoperative pain after gynecological surgery

    Self-reported pain intensity using a standard visual analogue scale (VAS, from 0 to 10) in patients after gynecological surgery.

    48 hours

  • Concentration of proinflammatory and pain factors in patients on postoperative pain after gynecological surgery

    Change in concentrations of individual cytokines (IL-1ß, IL-6) and hormones (catecholamines, cortisol) related to inflammation and pain

    Before surgery and 6, 24 and 48 hours after surgery

  • Quality of recovery after gynecological surgery

    The impact of three forms of postoperative analgesia (TAP block, systemic multimodal analgesia and combined TAP block and systemic multimodal analgesia) on the quality of recovery in patients after gynecological surgery, measured by using a widely accepted 40-item Quality of Recovery (QoR) questionnaire

    30 days

Study Arms (3)

Systemic multimodal analgesia only

ACTIVE COMPARATOR

In the first group, patients will receive intravenous, systemic, multimodal analgesia: paracetamol 1 gram and ketoprofen 100 mg every 8 hours for 24 hours. Analgesia will start immediately after surgery. If the pain persists, the patient will be given "rescue" analgesia: tramadol 50 mg intravenously up to a maximum dose of 400 mg / 24 h and other analgesics if needed.

Drug: Systemic multimodal analgesia administered intravenously

TAP block only

EXPERIMENTAL

In the second group there will be patients in who will be given the TAP block. The TAP block will be given postoperatively before waking. It will be given bilaterally in the before mentioned anatomic region (the so-called lateral TAP block) of 0.25% levobupivacaine in 40 ml bilaterally. If such analgesia is not satisfactory, tramadol 50 mg intravenously, up to a maximum dose of 400 mg / 24h, and other analgesics will be given at the request of the patient.

Procedure: Transversus abdominis plane block (TAP block)

Combined TAP block with systemic multimodal analgesia

EXPERIMENTAL

In the third group there will be patients who will be treated with TAP block in addition to systemic, mutimodal analgesia. If such analgesia is not satisfactory, tramadol 50 mg intravenously, up to a maximum dose of 400 mg / 24h, and other analgesics will be given at the request of the patient.

Other: Combined transversus abdominis plane block (TAP block) with systemic multimodal analgesia administered intravenously

Interventions

Paracetamol 1 gram and ketoprofen 100 mg every 8 hours for 24 hours. Analgesia will start immediately after surgery. If the pain persists, the patient will be given "rescue" analgesia: tramadol 50 mg intravenously up to a maximum dose of 400 mg / 24 h and other analgesics if needed.

Systemic multimodal analgesia only

The TAP block will be given postoperatively before waking. It will be given bilaterally in the before mentioned anatomic region (the so-called lateral TAP block) of 0.25% levobupivacin in 40 ml bilaterally. If the pain persists, the patient will be given "rescue" analgesia: tramadol 50 mg intravenously up to a maximum dose of 400 mg / 24 h and other analgesics if needed.

TAP block only

TAP block in addition to systemic, mutimodal analgesia. If such analgesia is not satisfactory, tramadol 50 mg intravenously, up to a maximum dose of 400 mg / 24h, and other analgesics will be given at the request of the patient.

Combined TAP block with systemic multimodal analgesia

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a benign gynecological condition, who underwent hysterectomy by laparotomy approach.

You may not qualify if:

  • under aged
  • pregnant women,
  • patients with malignant gynecological disease,
  • those with anesthesiologic risk of ASA III or more,
  • persons who are hypersensitive to anesthetics and analgesics,
  • patients who do not agree with the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

GH Pula

Pula, 52100, Croatia

RECRUITING

Clinical centre Rijeka

Rijeka, 51000, Croatia

RECRUITING

Related Publications (8)

  • Young MJ, Gorlin AW, Modest VE, Quraishi SA. Clinical implications of the transversus abdominis plane block in adults. Anesthesiol Res Pract. 2012;2012:731645. doi: 10.1155/2012/731645. Epub 2012 Jan 19.

    PMID: 22312327BACKGROUND
  • McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. doi: 10.1213/01.ane.0000250223.49963.0f.

    PMID: 17179269BACKGROUND
  • Abdallah FW, Chan VW, Brull R. Transversus abdominis plane block: a systematic review. Reg Anesth Pain Med. 2012 Mar-Apr;37(2):193-209. doi: 10.1097/AAP.0b013e3182429531.

    PMID: 22286518BACKGROUND
  • Yoshida T, Furutani K, Watanabe Y, Ohashi N, Baba H. Analgesic efficacy of bilateral continuous transversus abdominis plane blocks using an oblique subcostal approach in patients undergoing laparotomy for gynaecological cancer: a prospective, randomized, triple-blind, placebo-controlled study. Br J Anaesth. 2016 Dec;117(6):812-820. doi: 10.1093/bja/aew339.

    PMID: 27956680BACKGROUND
  • Dai C, Zhang K, Huang J. The Efficacy of Transversus Abdominis Plane Block for Abdominal Hysterectomy Post-operative Analgesia. Cureus. 2018 Aug 10;10(8):e3131. doi: 10.7759/cureus.3131.

    PMID: 30345190BACKGROUND
  • Easterday CL, Grimes DA, Riggs JA. Hysterectomy in the United States. Obstet Gynecol. 1983 Aug;62(2):203-12.

    PMID: 6408544BACKGROUND
  • American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012 Feb;116(2):248-73. doi: 10.1097/ALN.0b013e31823c1030. No abstract available.

    PMID: 22227789BACKGROUND
  • Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008.

    PMID: 26827847BACKGROUND

MeSH Terms

Conditions

LeiomyomaPelvic Organ ProlapseMetrorrhagiaChronic PainEndometriosisPain, Postoperative

Condition Hierarchy (Ancestors)

Neoplasms, Muscle TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUterine HemorrhageUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPainNeurologic ManifestationsSigns and SymptomsPostoperative Complications

Study Officials

  • Tomislav Perkov, MD

    GH Pula

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dean Markić, MD, PHD, Prof.

CONTACT

Ivana Miletović, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 8, 2019

First Posted

November 21, 2019

Study Start

September 24, 2019

Primary Completion

September 24, 2020

Study Completion

December 31, 2021

Last Updated

November 21, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations